Our study identified the critical roles of PAR1 in EMT induction and maintenance of CSCs properties of invasive breast cancer cells, and knockdown of PAR1 expression efficiently reverted these functions, implying that PAR1 may be a potentially valuable molecular target for treating invasive breast cancer. The gene discussed is F2R; the disease is invasive breast carcinoma.